ArticleVaccines2024

Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth.

Martin R Ramos-Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.